Millendo Therapeutics, Inc. Financial Statements 2011-2024 | MLND

Annual Financial Statements Millendo Therapeutics, Inc.

	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	2.5 M	7.73 M	1.06 M	2.59 M	3.26 M	10.2 M	65.6 M	10.1 M	3.26 M	-
Shares	1.27 M	914 K	103 K	159 K	143 K	120 K	101 K	71.8 K	25.8 K	-
Net Income	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Operating Expenses	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency